Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice
Authors
Keywords
-
Journal
Evidence-based Complementary and Alternative Medicine
Volume 2015, Issue -, Pages 1-5
Publisher
Hindawi Limited
Online
2015-03-18
DOI
10.1155/2015/239749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability
- (2014) Meng Zhaojie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy
- (2014) Li Qin Tang et al. MOLECULAR BIOLOGY REPORTS
- Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
- (2013) Mei Xue et al. International Journal of Nanomedicine
- Global burden of disease—where does diabetes mellitus fit in?
- (2013) K. George M. M. Alberti et al. Nature Reviews Endocrinology
- Diabetes: A Global Challenge With High Economic Burden for Public Health Systems and Society
- (2012) Armando Arredondo AMERICAN JOURNAL OF PUBLIC HEALTH
- Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart
- (2012) Wenguang Chang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride
- (2012) Jia-Xiao Zhu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
- (2012) Hui Dong et al. Evidence-based Complementary and Alternative Medicine
- Berberine and its derivatives: a patent review (2009 – 2012)
- (2012) Inder Pal Singh et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis
- (2012) Ming Zhang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
- (2012) Lei Gao et al. PHARMACEUTICAL RESEARCH
- Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
- (2012) Xu Zhang et al. PLoS One
- Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats
- (2011) Wei Chen et al. AAPS PHARMSCITECH
- Anti-Diabetic Effects of a Coptis chinensis Containing New Traditional Chinese Medicine Formula in Type 2 Diabetic Rats
- (2011) Zhong Zhen et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
- (2011) Xuan Xia et al. PLoS One
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search